{"symbol":"ABT","fiscalQuarter":"Q3-2014","reportDate":"2014-10-22","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2014","postBrief":{"headline":"Abbott Labs Misses on EPS, Stock Down 1.89%","keyNumbers":[{"metric":"EPS","actual":"$0.54","expected":"N/A","surprise":"-9.85%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized a focus on innovation and cost management."],"summary":"Management acknowledged the tough environment but expressed confidence in their long-term strategy. They are committed to improving operational efficiency."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported earnings that fell short of expectations, leading to a decline in stock price by 1.89%. The miss on EPS suggests that the company is facing some challenges, which may affect investor confidence. However, management's focus on innovation and cost management indicates they are working to navigate these issues moving forward.","metaDescription":"Abbott Labs (ABT) Q3 2014 earnings: EPS missed expectations. Stock down 1.89%. Full breakdown."}}